Comparing the current results to its competitors, Utah Medical Products Inc reported Revenue decrease in the 2 quarter 2026 year on year by -11.11 %, despite the revenue increase by the most of its competitors of 13.76 %, recorded in the same quarter.
Utah Medical Products Inc's Comment on Competition and Industry Peers
UTMD operates in the U.S. medical device market, focusing on patient safety and device reliability. The company offers a variety of specialty medical devices, competing with at least two significant competitors for each device type. UTMD's products differ from competitors' devices in design and reliability, positioning them as substitutes rather than direct equivalents. The company faces challenges in marketing these differences and clinical benefits, particularly as access to hospital clinicians has become more restricted and clinician involvement in purchasing decisions has decreased, impacting UTMD's competitive position. In 2025, UTMD sold components and finished devices to 134 U.S. companies through original equipment manufacturer (OEM) sales, which do not compete with its direct sales. UTMD's largest former OEM customer, PendoTECH, accounted for 22% of sales in 2022 but declined to 1% in 2025, with UTMD ceasing orders from PendoTECH after mid-2025.
Angiodynamics Inc is a medical technology company that focuses on the development and commercialization of devices and treatments for minimally invasive procedures. Their business model centers around the manufacturing and sale of innovative medical devices such as catheters, lasers, and fluid systems used in the diagnosis and treatment of various vascular conditions. They primarily generate revenue through the sale of these products to healthcare providers and hospitals worldwide.
Zimvie Inc is a technology company that operates in the entertainment industry, offering a platform for users to stream and watch movies and TV shows online. They generate revenue by charging a subscription fee to users who access their extensive library of content.
Zimmer Biomet Holdings Inc operates as a global leader in musculoskeletal healthcare, focusing on the design, manufacture, and marketing of innovative medical devices for joint replacement, sports medicine, spine, and dental implants. Their business model emphasizes improving patient outcomes and advancing the field through advanced surgical products and solutions targeted at healthcare professionals worldwide.
Sources:
Utah Medical Products Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Utah Medical Products Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
